Anson Funds Management’s Erasca ERAS Stock Holding History

Anson Funds Management’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-223,601	Closed	-$476K	–	172
2023 Q4	$476K	Buy	+223,601	New	+$472K	0.06%	130

Other funds holding ERAS

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Anson Funds Management's ERAS Position: Q1 2024 in Review

Anson Funds Management sold out of Erasca (ERAS) in Q1 2024, closing a stake of 223,601 shares — an estimated $476K sold.

Anson Funds Management first reported a position in ERAS in Q4 2023 and held it in 1 quarter. The position peaked at $476K in Q4 2023. 108 funds tracked by Wall St. Rank hold ERAS as of Q1 2024.

Anson Funds Management reported no remaining Erasca position as of Q1 2024 after selling out during the quarter.
Anson Funds Management sold 223,601 Erasca shares in Q1 2024, an estimated $476K.
Anson Funds Management first reported a position in Erasca in Q4 2023 and held it in 1 quarter.
Anson Funds Management's Erasca position peaked at $476K in Q4 2023.
108 funds tracked by Wall St. Rank held Erasca as of Q1 2024.

Based on Anson Funds Management's 13F filing for Q1 2024, filed 14 May 2024.